Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines. The research will be under the direction of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
generic viagra online
Your Ex-Factor: Overcome Heartbreak And Build A Better Life After Divorce Or Break-up - New Book
Over two-thirds of American families are "blended," which means they are made up of remarried adults and often stepchildren. Although it"s good news that many divorced people remarry, the bad news is that too many of them carry the animosities and negative behavior patterns of their former heartbreaks into their new situation.
News of the day
International Fertility Federation Comment On Human Reproduction Survey On Assisted Reproduction
The journal Human Reproduction reports the results of a survey which shows that ART (Assisted Reproduction Technology) is now responsible for 250,000 babies being born worldwide every year. The IFFS (International Federation of Fertility Societies), which represents most of the world"s fertility societies, has issued the following quote, which can be used as background material for any article on the Human Reproduction survey. This quote is embargoed to coincide with the Human Reproduction survey.
Mental Health

Statins Can Protect Against Alzheimer's Disease, According To New Study

High cholesterol levels are considered to be a risk factor not only for cardiovascular disease including stroke, but also for the development of Alzheimer"s disease. Therefore, many cholesterol lowering drugs, including statins, have been developed in recent years. In addition to the cholesterol reducing effect of statins Amalia Dolga, PhD, of the University of Groningen, The Netherlands, and her co-investigators have demonstrated that statins can protect nerve cells against damage which we know to occur in the brain of Alzheimer"s disease patients. The results are published in the June issue of the Journal of Alzheimer"s Disease. How nerve cells die in Alzheimer"s disease is complex but we know that nerve cells eventually die because they are strongly overstimulated, a process called excitotoxicity. In animal experiments conducted in the laboratory of Professor Ulrich Eisel, Department of Molecular Neurobiology, University of Groningen, Dolga and colleagues overstimulated such nerve cells. They clearly demonstrated that treatment with a statin called Lovastatin could prevent the death of nerve cells under these conditions. The statins not only prevented cells from dying but also prevented the loss of memory capacity that normally occurs after such cell death. In a previous study Dolga had showed that these statins stimulate the protective capacity of tumor necrosis factor, which is a key player in the brain"s immune response. Dolga has demonstrated in animal experiments that this tumor necrosis factor has a strong beneficial effect on nerve cells and can protect nerve cells against death. A widely prescribed drug like statins can activate this protective pathway revealing strong beneficial effect. The article "Pretreatment with Lovastatin Prevents N-Methyl-D-Aspartate-Induced Neurodegeneration in the Magnocellular Nucleus Basalis and Behavioral Dysfunction" Amalia M. Dolga, Ivica Granic, Ingrid M. Nijholt, Csaba Nyakas, Eddy A. van der Zee, Paul G. M. Luiten, and Ulrich L. M. Eisel is published in Volume 17:2 (June 2009) of the Journal of Alzheimer"s Disease. Astrid Engelen IOS Press


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009